Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Clinical and Translational Science|April 28, 2022
A public-private collaboration model for clinical innovationCraig D Wegner, Bobbie Ann Mount, Christine M Colvis
Drug Discovery Today|October 27, 2023
Illuminating the druggable genome: Pathways to progressKarlie R Sharma, Christine M Colvis, Griffin P Rodgers, et al.
Annual Review of Medicine|January 30, 2004
The impact of the completed human genome sequence on the development of novel therapeutics for human diseaseChristopher P Austin
Clinical and Translational Science|May 13, 2021
Opportunities and challenges in translational scienceChristopher P Austin
Current Opinion in Chemical Biology|August 28, 2003
The completed human genome: implications for chemical biologyChristopher P Austin
Drug Discovery Today|February 19, 2022
Defining clinical outcome pathwaysDaniel Korn, Andrew J Thieme, Vinicius M Alves, et al.
The Journal of Comparative Neurology|September 11, 2003
Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization studyPaul J Shughrue, Betty Ky, Christopher P Austin
The AAPS Journal|April 25, 2012
Paradigm shift in toxicity testing and modelingHongmao Sun, Menghang Xia, Christopher P Austin, et al.
Advances in Experimental Medicine and Biology|December 8, 2017
A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC)Christine M Cutillo, Christopher P Austin, Stephen C Groft
Human Molecular Genetics|June 19, 2003
DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutationJill A Morris, Geeta Kandpal, Lei Ma, et al.
Pageof 20